Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism

BACKGROUND: Radiotherapy has been used increasingly to treat primary hepatocellular carcinoma. Clinically, the main cause of radiotherapy failure is cellular radioresistance, conferred via glycolytic metabolism. Our previous study demonstrated that Girdin is upregulated in primary hepatocellular car...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Exp Clin Cancer Res
Päätekijät: Yu, Li, Sun, Yifan, Li, Jingjing, Wang, Yan, Zhu, Yuxing, Shi, Yong, Fan, Xiaojun, Zhou, Jianda, Bao, Ying, Xiao, Jie, Cao, Ke, Cao, Peiguo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5558715/
https://ncbi.nlm.nih.gov/pubmed/28810896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0580-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia